aluates Reports

$ 0.0

Automative

Global PRRS Vaccines Market Research Report 2025

Published Date: May 2025

Report Code: QYRE-Auto-3T2434

Global PRRS Vaccines Market Insights and Forecast to 2028

BUY CHAPTERS

Global PRRS Vaccines Market Research Report 2025

Code: QYRE-Auto-3T2434

Report

May 2025

Pages:115

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

MSD Animal Health

Ceva

CAVAC

Komipharm

Agrovet

Bioveta

Zoetis Inc

China Animal Husbandry Co. Ltd.

Boehringer Ingelheim

Sinopharm Animal Health

Ruipu Biological

Qilu Animal Health

DAHUANONG

Jinyu

Phibro Animal Health

Tiankang

Pulike Biological

Yongshun Biological

PRRS Vaccines Market Size

The global market for PRRS Vaccines was valued at US$ 410 million in the year 2024 and is projected to reach a revised size of US$ 527 million by 2031, growing at a CAGR of 3.5% during the forecast period.

PRRS Vaccines Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on PRRS Vaccines competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

There are two types of PRRS vaccines that are commercially available. One is a modified-live virus (MLV) vaccine and the other is a killed virus (KV) vaccine. PRRS MLV vaccine is well recognized for its protective efficacy against PRRSV that are genetically homologous to the vaccine virus.Porcine Reproductive and Respiratory Syndrome (PRRS) vaccine is a biological product designed to prevent and control PRRS, a highly contagious viral disease that affects pigs. The vaccine works by stimulating the pig's immune system to produce a protective response against the PRRS virus, thereby reducing reproductive failures such as abortions and stillbirths in sows, as well as respiratory illness and mortality in piglets and growing pigs. PRRS vaccines are typically classified into modified live vaccines (MLVs) and inactivated vaccines, and they play a critical role in improving herd health and productivity in the swine industry worldwide.

The global PRRS vaccine market is primarily driven by the widespread prevalence and economic impact of Porcine Reproductive and Respiratory Syndrome in the swine industry. PRRS is one of the most devastating diseases affecting pigs, causing significant reproductive losses in breeding herds and severe respiratory distress in growing pigs. The virus's ability to mutate and persist in herds has made it difficult to eradicate, leading to chronic infections and substantial financial losses for pig farmers. As a result, governments and veterinary authorities in major pork-producing countries such as China, the United States, and countries in the European Union have emphasized vaccination as a critical component of disease control programs. Additionally, rising global pork consumption is pressuring producers to maintain healthier herds and ensure consistent productivity, further boosting demand for effective PRRS vaccines. Technological advancements in vaccine formulation—such as the development of region-specific or genotype-specific modified live vaccines (MLVs)—have improved vaccine efficacy, making immunization a more reliable and widely accepted preventive measure. Moreover, increasing biosecurity awareness and the integration of vaccination into herd health management systems are reinforcing the growth of the PRRS vaccine market globally.

Despite its importance, the PRRS vaccine market faces several challenges that limit its effectiveness and adoption in certain regions. One of the primary issues is the virus's high genetic variability, which complicates the development of universally effective vaccines. The presence of multiple genotypes and frequent mutations means that vaccine strains may not provide cross-protection against all circulating variants, leading to inconsistent results and partial immunity in vaccinated herds. Additionally, modified live vaccines (MLVs), while generally more effective than inactivated ones, carry risks of reversion to virulence or recombination with field strains, which raises safety concerns among producers and regulatory bodies. In developing regions, limited access to veterinary services, cold chain logistics, and affordability issues further hinder the widespread adoption of PRRS vaccination programs. Moreover, there remains a lack of standardized vaccination protocols across countries, and vaccine performance can vary depending on farm conditions, pig genetics, and co-infections with other pathogens. These factors make disease management complex and can reduce confidence in vaccination strategies. Overcoming these challenges requires continued investment in research and development of next-generation vaccines, improved diagnostic tools for strain identification, and stronger government support for vaccination campaigns and swine health education.

Report Scope

This report aims to provide a comprehensive presentation of the global market for PRRS Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding PRRS Vaccines.

The PRRS Vaccines market size, estimations, and forecasts are provided in terms of output/shipments (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global PRRS Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the PRRS Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of PRRS Vaccines Market Report

Report Metric	Details
Report Name	PRRS Vaccines Market
Accounted market size in year	US$ 410 million
Forecasted market size in 2031	US$ 527 million
CAGR	3.5%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Live Vaccines Killed Vaccines
Segment by Application	Government Tender Market Sales
Production by Region	North America Europe China Japan
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	China Animal Husbandry Co., Ltd., Boehringer Ingelheim, MSD Animal Health, Sinopharm Animal Health, Ceva, Ruipu Biological, Qilu Animal Health, Dahuanong, CAVAC, Komipharm, Agrovet, Bioveta, Jinyu, Phibro Animal Health, Tiankang, Zoetis, Yongshun Biological, Pulike Biological
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of PRRS Vaccines manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of PRRS Vaccines by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of PRRS Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.

FAQ for this report

How fast is PRRS Vaccines Market growing?

Ans: The PRRS Vaccines Market witnessing a CAGR of 3.5% during the forecast period 2025-2031.

What is the PRRS Vaccines Market size in 2031?

Ans: The PRRS Vaccines Market size in 2031 will be US$ 527 million.

Who are the main players in the PRRS Vaccines Market report?

Ans: The main players in the PRRS Vaccines Market are China Animal Husbandry Co., Ltd., Boehringer Ingelheim, MSD Animal Health, Sinopharm Animal Health, Ceva, Ruipu Biological, Qilu Animal Health, Dahuanong, CAVAC, Komipharm, Agrovet, Bioveta, Jinyu, Phibro Animal Health, Tiankang, Zoetis, Yongshun Biological, Pulike Biological

What are the Application segmentation covered in the PRRS Vaccines Market report?

Ans: The Applications covered in the PRRS Vaccines Market report are Government Tender, Market Sales

What are the Type segmentation covered in the PRRS Vaccines Market report?

Ans: The Types covered in the PRRS Vaccines Market report are Live Vaccines, Killed Vaccines

1 PRRS Vaccines Market Overview

1.1 Product Definition

1.2 PRRS Vaccines by Type

1.2.1 Global PRRS Vaccines Market Value Growth Rate Analysis by Type: 2024 VS 2031

1.2.2 Live Vaccines

1.2.3 Killed Vaccines

1.3 PRRS Vaccines by Application

1.3.1 Global PRRS Vaccines Market Value Growth Rate Analysis by Application: 2024 VS 2031

1.3.2 Government Tender

1.3.3 Market Sales

1.4 Global Market Growth Prospects

1.4.1 Global PRRS Vaccines Production Value Estimates and Forecasts (2020-2031)

1.4.2 Global PRRS Vaccines Production Capacity Estimates and Forecasts (2020-2031)

1.4.3 Global PRRS Vaccines Production Estimates and Forecasts (2020-2031)

1.4.4 Global PRRS Vaccines Market Average Price Estimates and Forecasts (2020-2031)

1.5 Assumptions and Limitations

2 Market Competition by Manufacturers

2.1 Global PRRS Vaccines Production Market Share by Manufacturers (2020-2025)

2.2 Global PRRS Vaccines Production Value Market Share by Manufacturers (2020-2025)

2.3 Global Key Players of PRRS Vaccines, Industry Ranking, 2023 VS 2024

2.4 Global PRRS Vaccines Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.5 Global PRRS Vaccines Average Price by Manufacturers (2020-2025)

2.6 Global Key Manufacturers of PRRS Vaccines, Manufacturing Base Distribution and Headquarters

2.7 Global Key Manufacturers of PRRS Vaccines, Product Offered and Application

2.8 Global Key Manufacturers of PRRS Vaccines, Date of Enter into This Industry

2.9 PRRS Vaccines Market Competitive Situation and Trends

2.9.1 PRRS Vaccines Market Concentration Rate

2.9.2 Global 5 and 10 Largest PRRS Vaccines Players Market Share by Revenue

2.10 Mergers & Acquisitions, Expansion

3 PRRS Vaccines Production by Region

3.1 Global PRRS Vaccines Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031

3.2 Global PRRS Vaccines Production Value by Region (2020-2031)

3.2.1 Global PRRS Vaccines Production Value by Region (2020-2025)

3.2.2 Global Forecasted Production Value of PRRS Vaccines by Region (2026-2031)

3.3 Global PRRS Vaccines Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031

3.4 Global PRRS Vaccines Production Volume by Region (2020-2031)

3.4.1 Global PRRS Vaccines Production by Region (2020-2025)

3.4.2 Global Forecasted Production of PRRS Vaccines by Region (2026-2031)

3.5 Global PRRS Vaccines Market Price Analysis by Region (2020-2025)

3.6 Global PRRS Vaccines Production and Value, Year-over-Year Growth

3.6.1 North America PRRS Vaccines Production Value Estimates and Forecasts (2020-2031)

3.6.2 Europe PRRS Vaccines Production Value Estimates and Forecasts (2020-2031)

3.6.3 China PRRS Vaccines Production Value Estimates and Forecasts (2020-2031)

3.6.4 Japan PRRS Vaccines Production Value Estimates and Forecasts (2020-2031)

4 PRRS Vaccines Consumption by Region

4.1 Global PRRS Vaccines Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031

4.2 Global PRRS Vaccines Consumption by Region (2020-2031)

4.2.1 Global PRRS Vaccines Consumption by Region (2020-2025)

4.2.2 Global PRRS Vaccines Forecasted Consumption by Region (2026-2031)

4.3 North America

4.3.1 North America PRRS Vaccines Consumption Growth Rate by Country: 2020 VS 2024 VS 2031

4.3.2 North America PRRS Vaccines Consumption by Country (2020-2031)

4.3.3 U.S.

4.3.4 Canada

4.4 Europe

4.4.1 Europe PRRS Vaccines Consumption Growth Rate by Country: 2020 VS 2024 VS 2031

4.4.2 Europe PRRS Vaccines Consumption by Country (2020-2031)

4.4.3 Germany

4.4.4 France

4.4.5 U.K.

4.4.6 Italy

4.4.7 Netherlands

4.5 Asia Pacific

4.5.1 Asia Pacific PRRS Vaccines Consumption Growth Rate by Region: 2020 VS 2024 VS 2031

4.5.2 Asia Pacific PRRS Vaccines Consumption by Region (2020-2031)

4.5.3 China

4.5.4 Japan

4.5.5 South Korea

4.5.6 China Taiwan

4.5.7 Southeast Asia

4.5.8 India

4.6 Latin America, Middle East & Africa

4.6.1 Latin America, Middle East & Africa PRRS Vaccines Consumption Growth Rate by Country: 2020 VS 2024 VS 2031

4.6.2 Latin America, Middle East & Africa PRRS Vaccines Consumption by Country (2020-2031)

4.6.3 Mexico

4.6.4 Brazil

4.6.5 Turkey

4.6.6 GCC Countries

5 Segment by Type

5.1 Global PRRS Vaccines Production by Type (2020-2031)

5.1.1 Global PRRS Vaccines Production by Type (2020-2025)

5.1.2 Global PRRS Vaccines Production by Type (2026-2031)

5.1.3 Global PRRS Vaccines Production Market Share by Type (2020-2031)

5.2 Global PRRS Vaccines Production Value by Type (2020-2031)

5.2.1 Global PRRS Vaccines Production Value by Type (2020-2025)

5.2.2 Global PRRS Vaccines Production Value by Type (2026-2031)

5.2.3 Global PRRS Vaccines Production Value Market Share by Type (2020-2031)

5.3 Global PRRS Vaccines Price by Type (2020-2031)

6 Segment by Application

6.1 Global PRRS Vaccines Production by Application (2020-2031)

6.1.1 Global PRRS Vaccines Production by Application (2020-2025)

6.1.2 Global PRRS Vaccines Production by Application (2026-2031)

6.1.3 Global PRRS Vaccines Production Market Share by Application (2020-2031)

6.2 Global PRRS Vaccines Production Value by Application (2020-2031)

6.2.1 Global PRRS Vaccines Production Value by Application (2020-2025)

6.2.2 Global PRRS Vaccines Production Value by Application (2026-2031)

6.2.3 Global PRRS Vaccines Production Value Market Share by Application (2020-2031)

6.3 Global PRRS Vaccines Price by Application (2020-2031)

7 Key Companies Profiled

7.1 China Animal Husbandry Co., Ltd.

7.1.1 China Animal Husbandry Co., Ltd. PRRS Vaccines Company Information

7.1.2 China Animal Husbandry Co., Ltd. PRRS Vaccines Product Portfolio

7.1.3 China Animal Husbandry Co., Ltd. PRRS Vaccines Production, Value, Price and Gross Margin (2020-2025)

7.1.4 China Animal Husbandry Co., Ltd. Main Business and Markets Served

7.1.5 China Animal Husbandry Co., Ltd. Recent Developments/Updates

7.2 Boehringer Ingelheim

7.2.1 Boehringer Ingelheim PRRS Vaccines Company Information

7.2.2 Boehringer Ingelheim PRRS Vaccines Product Portfolio

7.2.3 Boehringer Ingelheim PRRS Vaccines Production, Value, Price and Gross Margin (2020-2025)

7.2.4 Boehringer Ingelheim Main Business and Markets Served

7.2.5 Boehringer Ingelheim Recent Developments/Updates

7.3 MSD Animal Health

7.3.1 MSD Animal Health PRRS Vaccines Company Information

7.3.2 MSD Animal Health PRRS Vaccines Product Portfolio

7.3.3 MSD Animal Health PRRS Vaccines Production, Value, Price and Gross Margin (2020-2025)

7.3.4 MSD Animal Health Main Business and Markets Served

7.3.5 MSD Animal Health Recent Developments/Updates

7.4 Sinopharm Animal Health

7.4.1 Sinopharm Animal Health PRRS Vaccines Company Information

7.4.2 Sinopharm Animal Health PRRS Vaccines Product Portfolio

7.4.3 Sinopharm Animal Health PRRS Vaccines Production, Value, Price and Gross Margin (2020-2025)

7.4.4 Sinopharm Animal Health Main Business and Markets Served

7.4.5 Sinopharm Animal Health Recent Developments/Updates

7.5 Ceva

7.5.1 Ceva PRRS Vaccines Company Information

7.5.2 Ceva PRRS Vaccines Product Portfolio

7.5.3 Ceva PRRS Vaccines Production, Value, Price and Gross Margin (2020-2025)

7.5.4 Ceva Main Business and Markets Served

7.5.5 Ceva Recent Developments/Updates

7.6 Ruipu Biological

7.6.1 Ruipu Biological PRRS Vaccines Company Information

7.6.2 Ruipu Biological PRRS Vaccines Product Portfolio

7.6.3 Ruipu Biological PRRS Vaccines Production, Value, Price and Gross Margin (2020-2025)

7.6.4 Ruipu Biological Main Business and Markets Served

7.6.5 Ruipu Biological Recent Developments/Updates

7.7 Qilu Animal Health

7.7.1 Qilu Animal Health PRRS Vaccines Company Information

7.7.2 Qilu Animal Health PRRS Vaccines Product Portfolio

7.7.3 Qilu Animal Health PRRS Vaccines Production, Value, Price and Gross Margin (2020-2025)

7.7.4 Qilu Animal Health Main Business and Markets Served

7.7.5 Qilu Animal Health Recent Developments/Updates

7.8 Dahuanong

7.8.1 Dahuanong PRRS Vaccines Company Information

7.8.2 Dahuanong PRRS Vaccines Product Portfolio

7.8.3 Dahuanong PRRS Vaccines Production, Value, Price and Gross Margin (2020-2025)

7.8.4 Dahuanong Main Business and Markets Served

7.8.5 Dahuanong Recent Developments/Updates

7.9 CAVAC

7.9.1 CAVAC PRRS Vaccines Company Information

7.9.2 CAVAC PRRS Vaccines Product Portfolio

7.9.3 CAVAC PRRS Vaccines Production, Value, Price and Gross Margin (2020-2025)

7.9.4 CAVAC Main Business and Markets Served

7.9.5 CAVAC Recent Developments/Updates

7.10 Komipharm

7.10.1 Komipharm PRRS Vaccines Company Information

7.10.2 Komipharm PRRS Vaccines Product Portfolio

7.10.3 Komipharm PRRS Vaccines Production, Value, Price and Gross Margin (2020-2025)

7.10.4 Komipharm Main Business and Markets Served

7.10.5 Komipharm Recent Developments/Updates

7.11 Agrovet

7.11.1 Agrovet PRRS Vaccines Company Information

7.11.2 Agrovet PRRS Vaccines Product Portfolio

7.11.3 Agrovet PRRS Vaccines Production, Value, Price and Gross Margin (2020-2025)

7.11.4 Agrovet Main Business and Markets Served

7.11.5 Agrovet Recent Developments/Updates

7.12 Bioveta

7.12.1 Bioveta PRRS Vaccines Company Information

7.12.2 Bioveta PRRS Vaccines Product Portfolio

7.12.3 Bioveta PRRS Vaccines Production, Value, Price and Gross Margin (2020-2025)

7.12.4 Bioveta Main Business and Markets Served

7.12.5 Bioveta Recent Developments/Updates

7.13 Jinyu

7.13.1 Jinyu PRRS Vaccines Company Information

7.13.2 Jinyu PRRS Vaccines Product Portfolio

7.13.3 Jinyu PRRS Vaccines Production, Value, Price and Gross Margin (2020-2025)

7.13.4 Jinyu Main Business and Markets Served

7.13.5 Jinyu Recent Developments/Updates

7.14 Phibro Animal Health

7.14.1 Phibro Animal Health PRRS Vaccines Company Information

7.14.2 Phibro Animal Health PRRS Vaccines Product Portfolio

7.14.3 Phibro Animal Health PRRS Vaccines Production, Value, Price and Gross Margin (2020-2025)

7.14.4 Phibro Animal Health Main Business and Markets Served

7.14.5 Phibro Animal Health Recent Developments/Updates

7.15 Tiankang

7.15.1 Tiankang PRRS Vaccines Company Information

7.15.2 Tiankang PRRS Vaccines Product Portfolio

7.15.3 Tiankang PRRS Vaccines Production, Value, Price and Gross Margin (2020-2025)

7.15.4 Tiankang Main Business and Markets Served

7.15.5 Tiankang Recent Developments/Updates

7.16 Zoetis

7.16.1 Zoetis PRRS Vaccines Company Information

7.16.2 Zoetis PRRS Vaccines Product Portfolio

7.16.3 Zoetis PRRS Vaccines Production, Value, Price and Gross Margin (2020-2025)

7.16.4 Zoetis Main Business and Markets Served

7.16.5 Zoetis Recent Developments/Updates

7.17 Yongshun Biological

7.17.1 Yongshun Biological PRRS Vaccines Company Information

7.17.2 Yongshun Biological PRRS Vaccines Product Portfolio

7.17.3 Yongshun Biological PRRS Vaccines Production, Value, Price and Gross Margin (2020-2025)

7.17.4 Yongshun Biological Main Business and Markets Served

7.17.5 Yongshun Biological Recent Developments/Updates

7.18 Pulike Biological

7.18.1 Pulike Biological PRRS Vaccines Company Information

7.18.2 Pulike Biological PRRS Vaccines Product Portfolio

7.18.3 Pulike Biological PRRS Vaccines Production, Value, Price and Gross Margin (2020-2025)

7.18.4 Pulike Biological Main Business and Markets Served

7.18.5 Pulike Biological Recent Developments/Updates

8 Industry Chain and Sales Channels Analysis

8.1 PRRS Vaccines Industry Chain Analysis

8.2 PRRS Vaccines Raw Material Supply Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.3 PRRS Vaccines Production Mode & Process Analysis

8.4 PRRS Vaccines Sales and Marketing

8.4.1 PRRS Vaccines Sales Channels

8.4.2 PRRS Vaccines Distributors

8.5 PRRS Vaccines Customer Analysis

9 PRRS Vaccines Market Dynamics

9.1 PRRS Vaccines Industry Trends

9.2 PRRS Vaccines Market Drivers

9.3 PRRS Vaccines Market Challenges

9.4 PRRS Vaccines Market Restraints

10 Research Findings and Conclusion

11 Methodology and Data Source

11.1 Methodology/Research Approach

11.1.1 Research Programs/Design

11.1.2 Market Size Estimation

11.1.3 Market Breakdown and Data Triangulation

11.2 Data Source

11.2.1 Secondary Sources

11.2.2 Primary Sources

11.3 Author List

11.4 Disclaimer

FEATURED COMPANIES

MSD Animal Health

Ceva

CAVAC

Komipharm

Agrovet

Bioveta

Zoetis Inc

China Animal Husbandry Co. Ltd.

Boehringer Ingelheim

Sinopharm Animal Health

Ruipu Biological

Qilu Animal Health

DAHUANONG

Jinyu

Phibro Animal Health

Tiankang

Pulike Biological

Yongshun Biological

List of Tables

Table 1. Global PRRS Vaccines Market Value by Type, (US$ Million) & (2024 VS 2031)

Table 2. Global PRRS Vaccines Market Value by Application, (US$ Million) & (2024 VS 2031)

Table 3. Global PRRS Vaccines Production Capacity (K Units) by Manufacturers in 2024

Table 4. Global PRRS Vaccines Production by Manufacturers (2020-2025) & (K Units)

Table 5. Global PRRS Vaccines Production Market Share by Manufacturers (2020-2025)

Table 6. Global PRRS Vaccines Production Value by Manufacturers (2020-2025) & (US$ Million)

Table 7. Global PRRS Vaccines Production Value Share by Manufacturers (2020-2025)

Table 8. Global Key Players of PRRS Vaccines, Industry Ranking, 2023 VS 2024

Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value in PRRS Vaccines as of 2024)

Table 10. Global Market PRRS Vaccines Average Price by Manufacturers (USD/Unit) & (2020-2025)

Table 11. Global Key Manufacturers of PRRS Vaccines, Manufacturing Base Distribution and Headquarters

Table 12. Global Key Manufacturers of PRRS Vaccines, Product Offered and Application

Table 13. Global Key Manufacturers of PRRS Vaccines, Date of Enter into This Industry

Table 14. Global PRRS Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global PRRS Vaccines Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 17. Global PRRS Vaccines Production Value (US$ Million) by Region (2020-2025)

Table 18. Global PRRS Vaccines Production Value Market Share by Region (2020-2025)

Table 19. Global PRRS Vaccines Production Value (US$ Million) Forecast by Region (2026-2031)

Table 20. Global PRRS Vaccines Production Value Market Share Forecast by Region (2026-2031)

Table 21. Global PRRS Vaccines Production Comparison by Region: 2020 VS 2024 VS 2031 (K Units)

Table 22. Global PRRS Vaccines Production (K Units) by Region (2020-2025)

Table 23. Global PRRS Vaccines Production Market Share by Region (2020-2025)

Table 24. Global PRRS Vaccines Production (K Units) Forecast by Region (2026-2031)

Table 25. Global PRRS Vaccines Production Market Share Forecast by Region (2026-2031)

Table 26. Global PRRS Vaccines Market Average Price (USD/Unit) by Region (2020-2025)

Table 27. Global PRRS Vaccines Market Average Price (USD/Unit) by Region (2026-2031)

Table 28. Global PRRS Vaccines Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (K Units)

Table 29. Global PRRS Vaccines Consumption by Region (2020-2025) & (K Units)

Table 30. Global PRRS Vaccines Consumption Market Share by Region (2020-2025)

Table 31. Global PRRS Vaccines Forecasted Consumption by Region (2026-2031) & (K Units)

Table 32. Global PRRS Vaccines Forecasted Consumption Market Share by Region (2026-2031)

Table 33. North America PRRS Vaccines Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (K Units)

Table 34. North America PRRS Vaccines Consumption by Country (2020-2025) & (K Units)

Table 35. North America PRRS Vaccines Consumption by Country (2026-2031) & (K Units)

Table 36. Europe PRRS Vaccines Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (K Units)

Table 37. Europe PRRS Vaccines Consumption by Country (2020-2025) & (K Units)

Table 38. Europe PRRS Vaccines Consumption by Country (2026-2031) & (K Units)

Table 39. Asia Pacific PRRS Vaccines Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (K Units)

Table 40. Asia Pacific PRRS Vaccines Consumption by Region (2020-2025) & (K Units)

Table 41. Asia Pacific PRRS Vaccines Consumption by Region (2026-2031) & (K Units)

Table 42. Latin America, Middle East & Africa PRRS Vaccines Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (K Units)

Table 43. Latin America, Middle East & Africa PRRS Vaccines Consumption by Country (2020-2025) & (K Units)

Table 44. Latin America, Middle East & Africa PRRS Vaccines Consumption by Country (2026-2031) & (K Units)

Table 45. Global PRRS Vaccines Production (K Units) by Type (2020-2025)

Table 46. Global PRRS Vaccines Production (K Units) by Type (2026-2031)

Table 47. Global PRRS Vaccines Production Market Share by Type (2020-2025)

Table 48. Global PRRS Vaccines Production Market Share by Type (2026-2031)

Table 49. Global PRRS Vaccines Production Value (US$ Million) by Type (2020-2025)

Table 50. Global PRRS Vaccines Production Value (US$ Million) by Type (2026-2031)

Table 51. Global PRRS Vaccines Production Value Market Share by Type (2020-2025)

Table 52. Global PRRS Vaccines Production Value Market Share by Type (2026-2031)

Table 53. Global PRRS Vaccines Price (USD/Unit) by Type (2020-2025)

Table 54. Global PRRS Vaccines Price (USD/Unit) by Type (2026-2031)

Table 55. Global PRRS Vaccines Production (K Units) by Application (2020-2025)

Table 56. Global PRRS Vaccines Production (K Units) by Application (2026-2031)

Table 57. Global PRRS Vaccines Production Market Share by Application (2020-2025)

Table 58. Global PRRS Vaccines Production Market Share by Application (2026-2031)

Table 59. Global PRRS Vaccines Production Value (US$ Million) by Application (2020-2025)

Table 60. Global PRRS Vaccines Production Value (US$ Million) by Application (2026-2031)

Table 61. Global PRRS Vaccines Production Value Market Share by Application (2020-2025)

Table 62. Global PRRS Vaccines Production Value Market Share by Application (2026-2031)

Table 63. Global PRRS Vaccines Price (USD/Unit) by Application (2020-2025)

Table 64. Global PRRS Vaccines Price (USD/Unit) by Application (2026-2031)

Table 65. China Animal Husbandry Co., Ltd. PRRS Vaccines Company Information

Table 66. China Animal Husbandry Co., Ltd. PRRS Vaccines Specification and Application

Table 67. China Animal Husbandry Co., Ltd. PRRS Vaccines Production (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 68. China Animal Husbandry Co., Ltd. Main Business and Markets Served

Table 69. China Animal Husbandry Co., Ltd. Recent Developments/Updates

Table 70. Boehringer Ingelheim PRRS Vaccines Company Information

Table 71. Boehringer Ingelheim PRRS Vaccines Specification and Application

Table 72. Boehringer Ingelheim PRRS Vaccines Production (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 73. Boehringer Ingelheim Main Business and Markets Served

Table 74. Boehringer Ingelheim Recent Developments/Updates

Table 75. MSD Animal Health PRRS Vaccines Company Information

Table 76. MSD Animal Health PRRS Vaccines Specification and Application

Table 77. MSD Animal Health PRRS Vaccines Production (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 78. MSD Animal Health Main Business and Markets Served

Table 79. MSD Animal Health Recent Developments/Updates

Table 80. Sinopharm Animal Health PRRS Vaccines Company Information

Table 81. Sinopharm Animal Health PRRS Vaccines Specification and Application

Table 82. Sinopharm Animal Health PRRS Vaccines Production (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 83. Sinopharm Animal Health Main Business and Markets Served

Table 84. Sinopharm Animal Health Recent Developments/Updates

Table 85. Ceva PRRS Vaccines Company Information

Table 86. Ceva PRRS Vaccines Specification and Application

Table 87. Ceva PRRS Vaccines Production (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 88. Ceva Main Business and Markets Served

Table 89. Ceva Recent Developments/Updates

Table 90. Ruipu Biological PRRS Vaccines Company Information

Table 91. Ruipu Biological PRRS Vaccines Specification and Application

Table 92. Ruipu Biological PRRS Vaccines Production (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 93. Ruipu Biological Main Business and Markets Served

Table 94. Ruipu Biological Recent Developments/Updates

Table 95. Qilu Animal Health PRRS Vaccines Company Information

Table 96. Qilu Animal Health PRRS Vaccines Specification and Application

Table 97. Qilu Animal Health PRRS Vaccines Production (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 98. Qilu Animal Health Main Business and Markets Served

Table 99. Qilu Animal Health Recent Developments/Updates

Table 100. Dahuanong PRRS Vaccines Company Information

Table 101. Dahuanong PRRS Vaccines Specification and Application

Table 102. Dahuanong PRRS Vaccines Production (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 103. Dahuanong Main Business and Markets Served

Table 104. Dahuanong Recent Developments/Updates

Table 105. CAVAC PRRS Vaccines Company Information

Table 106. CAVAC PRRS Vaccines Specification and Application

Table 107. CAVAC PRRS Vaccines Production (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 108. CAVAC Main Business and Markets Served

Table 109. CAVAC Recent Developments/Updates

Table 110. Komipharm PRRS Vaccines Company Information

Table 111. Komipharm PRRS Vaccines Specification and Application

Table 112. Komipharm PRRS Vaccines Production (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 113. Komipharm Main Business and Markets Served

Table 114. Komipharm Recent Developments/Updates

Table 115. Agrovet PRRS Vaccines Company Information

Table 116. Agrovet PRRS Vaccines Specification and Application

Table 117. Agrovet PRRS Vaccines Production (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 118. Agrovet Main Business and Markets Served

Table 119. Agrovet Recent Developments/Updates

Table 120. Bioveta PRRS Vaccines Company Information

Table 121. Bioveta PRRS Vaccines Specification and Application

Table 122. Bioveta PRRS Vaccines Production (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 123. Bioveta Main Business and Markets Served

Table 124. Bioveta Recent Developments/Updates

Table 125. Jinyu PRRS Vaccines Company Information

Table 126. Jinyu PRRS Vaccines Specification and Application

Table 127. Jinyu PRRS Vaccines Production (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 128. Jinyu Main Business and Markets Served

Table 129. Jinyu Recent Developments/Updates

Table 130. Phibro Animal Health PRRS Vaccines Company Information

Table 131. Phibro Animal Health PRRS Vaccines Specification and Application

Table 132. Phibro Animal Health PRRS Vaccines Production (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 133. Phibro Animal Health Main Business and Markets Served

Table 134. Phibro Animal Health Recent Developments/Updates

Table 135. Tiankang PRRS Vaccines Company Information

Table 136. Tiankang PRRS Vaccines Specification and Application

Table 137. Tiankang PRRS Vaccines Production (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 138. Tiankang Main Business and Markets Served

Table 139. Tiankang Recent Developments/Updates

Table 140. Zoetis PRRS Vaccines Company Information

Table 141. Zoetis PRRS Vaccines Specification and Application

Table 142. Zoetis PRRS Vaccines Production (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 143. Zoetis Main Business and Markets Served

Table 144. Zoetis Recent Developments/Updates

Table 145. Yongshun Biological PRRS Vaccines Company Information

Table 146. Yongshun Biological PRRS Vaccines Specification and Application

Table 147. Yongshun Biological PRRS Vaccines Production (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 148. Yongshun Biological Main Business and Markets Served

Table 149. Yongshun Biological Recent Developments/Updates

Table 150. Pulike Biological PRRS Vaccines Company Information

Table 151. Pulike Biological PRRS Vaccines Specification and Application

Table 152. Pulike Biological PRRS Vaccines Production (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 153. Pulike Biological Main Business and Markets Served

Table 154. Pulike Biological Recent Developments/Updates

Table 155. Key Raw Materials Lists

Table 156. Raw Materials Key Suppliers Lists

Table 157. PRRS Vaccines Distributors List

Table 158. PRRS Vaccines Customers List

Table 159. PRRS Vaccines Market Trends

Table 160. PRRS Vaccines Market Drivers

Table 161. PRRS Vaccines Market Challenges

Table 162. PRRS Vaccines Market Restraints

Table 163. Research Programs/Design for This Report

Table 164. Key Data Information from Secondary Sources

Table 165. Key Data Information from Primary Sources

Table 166. Authors List of This Report

List of Figures

Figure 1. Product Picture of PRRS Vaccines

Figure 2. Global PRRS Vaccines Market Value by Type, (US$ Million) & (2020-2031)

Figure 3. Global PRRS Vaccines Market Share by Type: 2024 VS 2031

Figure 4. Live Vaccines Product Picture

Figure 5. Killed Vaccines Product Picture

Figure 6. Global PRRS Vaccines Market Value by Application, (US$ Million) & (2020-2031)

Figure 7. Global PRRS Vaccines Market Share by Application: 2024 VS 2031

Figure 8. Government Tender

Figure 9. Market Sales

Figure 10. Global PRRS Vaccines Production Value (US$ Million), 2020 VS 2024 VS 2031

Figure 11. Global PRRS Vaccines Production Value (US$ Million) & (2020-2031)

Figure 12. Global PRRS Vaccines Production Capacity (K Units) & (2020-2031)

Figure 13. Global PRRS Vaccines Production (K Units) & (2020-2031)

Figure 14. Global PRRS Vaccines Average Price (USD/Unit) & (2020-2031)

Figure 15. PRRS Vaccines Report Years Considered

Figure 16. PRRS Vaccines Production Share by Manufacturers in 2024

Figure 17. Global PRRS Vaccines Production Value Share by Manufacturers (2024)

Figure 18. PRRS Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 19. The Global 5 and 10 Largest Players: Market Share by PRRS Vaccines Revenue in 2024

Figure 20. Global PRRS Vaccines Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)

Figure 21. Global PRRS Vaccines Production Value Market Share by Region: 2020 VS 2024 VS 2031

Figure 22. Global PRRS Vaccines Production Comparison by Region: 2020 VS 2024 VS 2031 (K Units)

Figure 23. Global PRRS Vaccines Production Market Share by Region: 2020 VS 2024 VS 2031

Figure 24. North America PRRS Vaccines Production Value (US$ Million) Growth Rate (2020-2031)

Figure 25. Europe PRRS Vaccines Production Value (US$ Million) Growth Rate (2020-2031)

Figure 26. China PRRS Vaccines Production Value (US$ Million) Growth Rate (2020-2031)

Figure 27. Japan PRRS Vaccines Production Value (US$ Million) Growth Rate (2020-2031)

Figure 28. Global PRRS Vaccines Consumption by Region: 2020 VS 2024 VS 2031 (K Units)

Figure 29. Global PRRS Vaccines Consumption Market Share by Region: 2020 VS 2024 VS 2031

Figure 30. North America PRRS Vaccines Consumption and Growth Rate (2020-2031) & (K Units)

Figure 31. North America PRRS Vaccines Consumption Market Share by Country (2020-2031)

Figure 32. U.S. PRRS Vaccines Consumption and Growth Rate (2020-2031) & (K Units)

Figure 33. Canada PRRS Vaccines Consumption and Growth Rate (2020-2031) & (K Units)

Figure 34. Europe PRRS Vaccines Consumption and Growth Rate (2020-2031) & (K Units)

Figure 35. Europe PRRS Vaccines Consumption Market Share by Country (2020-2031)

Figure 36. Germany PRRS Vaccines Consumption and Growth Rate (2020-2031) & (K Units)

Figure 37. France PRRS Vaccines Consumption and Growth Rate (2020-2031) & (K Units)

Figure 38. U.K. PRRS Vaccines Consumption and Growth Rate (2020-2031) & (K Units)

Figure 39. Italy PRRS Vaccines Consumption and Growth Rate (2020-2031) & (K Units)

Figure 40. Netherlands PRRS Vaccines Consumption and Growth Rate (2020-2031) & (K Units)

Figure 41. Asia Pacific PRRS Vaccines Consumption and Growth Rate (2020-2031) & (K Units)

Figure 42. Asia Pacific PRRS Vaccines Consumption Market Share by Region (2020-2031)

Figure 43. China PRRS Vaccines Consumption and Growth Rate (2020-2031) & (K Units)

Figure 44. Japan PRRS Vaccines Consumption and Growth Rate (2020-2031) & (K Units)

Figure 45. South Korea PRRS Vaccines Consumption and Growth Rate (2020-2031) & (K Units)

Figure 46. China Taiwan PRRS Vaccines Consumption and Growth Rate (2020-2031) & (K Units)

Figure 47. Southeast Asia PRRS Vaccines Consumption and Growth Rate (2020-2031) & (K Units)

Figure 48. India PRRS Vaccines Consumption and Growth Rate (2020-2031) & (K Units)

Figure 49. Latin America, Middle East & Africa PRRS Vaccines Consumption and Growth Rate (2020-2031) & (K Units)

Figure 50. Latin America, Middle East & Africa PRRS Vaccines Consumption Market Share by Country (2020-2031)

Figure 51. Mexico PRRS Vaccines Consumption and Growth Rate (2020-2031) & (K Units)

Figure 52. Brazil PRRS Vaccines Consumption and Growth Rate (2020-2031) & (K Units)

Figure 53. Turkey PRRS Vaccines Consumption and Growth Rate (2020-2031) & (K Units)

Figure 54. GCC Countries PRRS Vaccines Consumption and Growth Rate (2020-2031) & (K Units)

Figure 55. Global Production Market Share of PRRS Vaccines by Type (2020-2031)

Figure 56. Global Production Value Market Share of PRRS Vaccines by Type (2020-2031)

Figure 57. Global PRRS Vaccines Price (USD/Unit) by Type (2020-2031)

Figure 58. Global Production Market Share of PRRS Vaccines by Application (2020-2031)

Figure 59. Global Production Value Market Share of PRRS Vaccines by Application (2020-2031)

Figure 60. Global PRRS Vaccines Price (USD/Unit) by Application (2020-2031)

Figure 61. PRRS Vaccines Value Chain

Figure 62. Channels of Distribution (Direct Vs Distribution)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Blue Ear Pig Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Vaccine for Porcine Reproductive and Respiratory Syndrome PRRS Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RSV Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Poliomyelitis Vaccine Market Research Report 2025

Global Pet Recombinant Vaccine Market Research Report 2025

Global Highly Pathogenic Porcine Reproductive and Respiratory Syndrome Vaccine Live Market Research Report 2025

Global Polio Vaccination Market Research Report 2025

Inactivated Poliovirus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Animal Parvovirus Vaccine Market Research Report 2024

Poliovirus Vaccine Inactivated Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Combined Polio Vaccine Market Research Report 2024

Global Recombinant Vector Vaccines Market Insights Forecast to 2030

Poliovirus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Measles and Rubella Vaccine Market Research Report 2025

Measles Mumps and Rubella Virus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Swine Parvovirus Disease Vaccine Market Research Report 2024

Global Canine Vaccine Market Research Report 2024

Porcine Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

VLP Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions